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Abstract
Background: The etiology of the autoimmune thyroid diseases (AITDs), Graves’ disease (GD) and Hashimoto’s thyroiditis
(HT), is largely unknown. However, genetic susceptibility is believed to play a major role. Two whole genome scans from
Japan and from the US identified a locus on chromosome 8q24 that showed evidence for linkage with AITD and HT. Recent
studies have demonstrated an association between thyroglobulin (Tg) polymorphisms and AITD in Caucasians, suggesting
that Tg is a susceptibility gene on 8q24.
Objectives: The objective of the study was to refine Tg association with AITD, by analyzing a panel of 25 SNPs across an
extended 260 kb region of the Tg.
Methods: We studied 458 Japanese AITD patients (287 GD and 171 HT patients) and 221 matched Japanese control subjects
in association studies. Case-control association studies were performed using 25 Tg single nucleotide polymorphisms (SNPs)
chosen from a database of the Single Nucleotide Polymorphism Database (dbSNP). Haplotype analysis was undertaken
using the computer program SNPAlyze version 7.0.
Principal Findings and Conclusions: In total, 5 SNPs revealed association with GD (P,0.05), with the strongest SNP
associations at rs2256366 (P=0.002) and rs2687836 (P=0.0077), both located in intron 41 of the Tg gene. Because of the
strong LD between these two strongest associated variants, we performed the haplotype analysis, and identified a major
protective haplotype for GD (P=0.001).These results suggested that the Tg gene is involved in susceptibility for GD and
AITD in the Japanese.
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Introduction
Autoimmune thyroid diseases (AITDs), including Graves’
disease (GD) and Hashimoto’s thyroiditis (HT), are among the
most common human autoimmune diseases. The prevalence in
Caucasians is 1% [1,2], and the prevalence in Japanese may be
similar. GD is characterized clinically by hyperthyroidism, diffuse
goiter and the presence of thyrotropin receptor (TSHR) antibod-
ies. Some patients develop extrathyroidal manifestations, mainly
ophthalmopathy and dermopathy (reviewed by Davies [3]). HT is
characterized by apoptosis of thyrocytes leading to hypothyroidism
(reviewed by Weetman [4]). However, despite their contrasting
clinical presentations, GD and HT share many common features,
mainly the infiltration of the thyroid by T cells and the production
of anti-thyroid autoantibodies (anti-thyroglobulin and anti-thyroid
peroxidase antibodies) [3–5].
The pathogenesis of AITDs is thought to involve several risk
factors, including genetic risk factors (reviewed in [6]) and
environmental triggers such as cigarette smoking, iodine intake
and infection [7,8] (reviewed by Davies [3]). However, the
evidence for interactions between hereditary factors and environ-
mental influences appears to be much stronger for cigarette
smoking and iodine intake than for infections [8].
The first locus shown to be associated with AITDs was the
HLA-DRB1 locus (reviewed in [6]). HLA-DR3 (DRB1*03) has
been consistently shown to be associated with GD in Caucasians,
PLoS ONE | www.plosone.org 1 May 2012 | Volume 7 | Issue 5 | e37501with an odds ratio (OR) of 2.0–3.0 [9–11]. Other HLA alleles have
been shown to be associated with GD in non-Caucasian
populations (for a review see [12]). Non-HLA genes have also
been shown to influence the expression of GD. These genes
include the genes for CTLA-4 [13], CD40 [14], CD25 [15],
thyroglobulin (Tg) [16] and TSHR [17,18].
Two whole genome scans one from Japan [19] and one from
the US [20] identified a locus on chromosome 8q24, which
showed evidence for linkage with AITD and HT. The 8q24 locus
contains the thyroglobulin (Tg) gene, one of the major autoanti-
gens in AITD, and, thus, the Tg gene is a strong positional
candidate gene for AITD in this locus [21]. Indeed, the
microsatellite Tgms2, located inside intron 27 of the Tg gene,
showed evidence for linkage (LOD score=2.9) and association
(p=0.004) with AITD in a US dataset [16]. These results have
been replicated in a UK dataset [22], showing a significant
association between Tgms2 and AITD (p,0.001). Moreover, the
same Tgms2 allele was found to be associated with AITD in both
studies. Following these findings the entire Tg gene was sequenced
and , case control association studies for 14 novel Tg single
nucleotide polymorphisms (SNPs) in AITD patients and controls
showed that one SNP cluster (the exons 10–12 cluster) and an
exon 33 SNP were significantly associated with AITD [23].
Recently, we showed a significant association between Tgms2 and
HT in an independent Japanese cohort [24]. In the present study,
we performed a case-control study of AITD using 25 SNPs from
the Single Nucleotide Polymorphism Database (dbSNP) databases
spaced approximately 10–50 kb apart and spanning the Tg gene.
We found significant associations between SNPs in intron 41 and
GD.
Materials and Methods
Ethics Statement
The research protocol was approved by the Ethic Committee of
the Showa University Hospital and each subject signed the
informed consent form approved by the Institutional Review
Board at the Showa University Hospital.
Patients and Controls
AITD Patients. Four hundred and fifty-eight unrelated
Japanese AITD patients were studied. There were a total of 287
GD patients and 171 HT patients.
Clinical assessment. GD was diagnosed base on clinical
symptoms and biochemical confirmation of hyperthyroidism,
including diffuse goiter, elevated radioactive iodine uptake, and
elevated thyroid hormone levels. HT patients had documented
clinical and biochemical hypothyroidism requiring thyroid hor-
mone replacement therapy and showed autoantibodies against
thyroid peroxidase with or without antibodies against thyroglob-
ulin.
Controls. Two hundred and twenty-one age- and sex-
matched healthy Japanese volunteers served as controls in our
association studies. All controls had no personal or family history
of any autoimmune disease.
SNP typing
SNP selection was based on the HapMap Linkage disequilib-
rium (LD) blocks of the TG gene in Japanese so that the entire
gene had covereage [25]. Twenty-five intronic SNPs, many of
which were in the relationships without strong LD, in the Tg gene
were chosen from a database of dbSNP (Table S1). DNA was
extracted from whole blood using the Puregene kit (Gentra
Systems, Minneapolis, MN). All SNPs were genotyped by the
high-resolution melting and unlabeled probe methods using
LightScannerH (Idaho Technology Inc., Salt Lake City, Utah)
based on the manufacture’s protocol.
Statistical analysis
Case-control analysis and Hardy-Weinberg equilibrium (HWE)
test of SNP were performed using SNPALyze ver. 7.0 (Dynacom,
Yokohama, Japan) [26]. Differences in the allele frequencies
between the groups were analyzed using the chi square test and
Fisher’s exact test. The odds ratio (OR) was calculated using the
modified method of Woolf [27]. A p-value of ,0.05 was
considered statistically significant. HWE tests were carried out
for all loci among subjects and controls separately. Tests in
subjects and controls did not show any significant deviation from
HWE for any of the SNPs. Linkage disequilibrium (LD) between
SNPs was evaluated by the r
2 of pair-wise LD using SNPALyze
ver. 7.0 (Dynacom, see Table S1). Haplotype frequencies for
multiple loci were estimated by phase estimation using the
expectation-maximization (EM) algorithm. Permutation p values
were calculated by comparing haplotype frequencies between
cases and controls on the basis of 10,000 replications using
SNPALyze ver. 7.0.
Results
Case-control study
All cases and controls were in Hardy Weinberg Equilibrium.
Table 1 shows frequencies of these alleles in patients and controls
and the results of the case-control association analysis of alleles of
25 SNPs. With rs3739266 and rs2687836, we found significant
differences between allele frequencies in subjects and controls,
which were reflected in an increased frequency of the minor alleles
in AITD and GD (P,0.05), compared with frequencies in
controls. The evidence for association appears to be driven by
associations with GD. When allele frequencies were compared
between GD subjects and controls, all 4 SNPs in the interval
rs3739266 and rs2687836 showed evidence of association. In
contrast, there was little or no evidence of association between
these SNPs and HT alone. The strongest SNP associations are all
located within intron 41 of the Tg and are separated by just 5 kb;
these include rs2256366 (P=0.002) and rs2687836 (P=0.0077)
(Table 2).
Tg haplotype analysis
Because of the strong LD between the strongest two variants
(r
2=0.793, see Table 1), haplotype analysis was undertaken using
the computer program SNPAlyze version 7.0 (Table 3). Two
haplotyes (haplotypes #1 and #2) were relatively common and
haplotype #3 was rare. Distribution of the haplotype is
significantly different between GD and control by permutation
procedure (p=0.018). Haplotype #2, which contained the both
two SNPs’ risk alleles, was found to be positively associated with
GD and AITD (P=0.003 for GD, P=0.034 for AITD). In
contrast, haplotype #1, which did not contain the both two SNPs’
risk allele, was found to be protective (P=0.001 for GD, P=0.025
for AITD) (Table 3).
Discussion
We performed a case-control study using 25 SNPs located in the
Tg gene to test association with AITD, GD, and HT. We found a
significant association between AITD/GD/HT with several SNPs,
with strongest SNP associations at rs2256366 (P=0.002) and
rs2687836 (P=0.0077), both located in intron 41 of the Tg gene
Thyroglobulin Gene and AITD
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PLoS ONE | www.plosone.org 3 May 2012 | Volume 7 | Issue 5 | e37501(Tables 1 and 2). The Tg gene region has been previously shown
to be linked with AITD in a Japanese dataset of sib-pairs [19].
However, polymorphisms in the Tg gene itself have not been
previously studied for association with AITD in the Japanese.
Recently, amino acid sequence variants in the Tg gene were
reported to be associated with AITD [23]. In a Caucasian US
cohort one SNP cluster (the exons 10–12 cluster) and an exon 33
SNP were significantly associated with AITD [23]. Recently, One
from Taiwanese [28] found a significant increase in the T/T
genotype of the exon 33 SNP compared with the control group
(P,0.001). However, our preliminary data in Japanese HT
patients and controls showed that the exon 33 SNP of the Tg
gene was not associated with HT in the Japanese population,
suggesting that other SNP(s) of the Tg gene may be associated with
AITD [24]. Therefore, we now tested all reported Tg SNPs in our
cohort of Japanese AITD patients.
Tg is one of the three genes encoding major disease-specific
thyroid autoantigens, including also the thyroid peroxidase (TPO)
and TSH receptor (TSHR) genes. The association of Tg variants
with AITD demonstrates that thyroid specific genes, and not only
immune regulatory genes (e.g. HLA-DR, CTLA-4), are important
for susceptibility to AITD. Moreover, our results suggest that the
association of Tg with AITD is not specific to one population and
is observed across ethnic backgrounds, as had been shown for
CTLA-4 [29] and CD40 [30].
Polymorphisms in Tg gene have previously been studied in
different ethnic groups, US Caucasians [16,23], UK Caucasians
[22,31] and Japanese [24], making it possible to compare the
association of some of the polymorphisms in different ethnic
groups. For example, a microsatellite polymorphism in intron 27
(Tgms2) was studied in all three ethnic groups and significantly
association with AITD was reported in all studies [16,22,24]. In
contrast, exon 10–12 and exon 33 SNPs were significantly
associated with AITD in US dataset [23], but not in UK [31] or
Japanese (present study) datasets. Therefore, it is possible that the
genetic susceptibility to AITD involves both different polymor-
phisms in the same gene in different ethnic/geographic groups, as
well as common polymorphism that predisposes to AITD in
different ethnic/geographic groups. Tgms2 may be the common
polymorphism across ethnic and geographic groups.
It is likely that susceptibility to AITD involves an interaction
between several genes, including immune regulatory genes and
tissue specific genes, as well as environmental factors. Indeed,
previous analysis showed evidence for interaction between HLA-
DR3 and a Tg exon 33 SNP [23]. Recently, Hodge et al. [32]
demonstrated a possible interaction between the effects of
inheriting at least one copy of the DRb-Arg74 allele (R) of the
DRB1 gene and inheriting the homozygous CC genotype of the
exon 33 SNP. This proposed mechanism of immune-regulatory
genes interacting with autoantigen specific genes, may be a more
general mechanism for the development of organ-specific auto-
Table 2. Case–control association results for the two most highly GD associated SNPs.
SNP Name
Allele/
Genotype Control (n=221) AITD (n=458) P value
a GD (n=287) P value
a HT (n=171) P value
a
rs2256366 T 248 (56.1) 452 (49.3) 266 (46.3) 452 (54.4)
C 194 (43.9) 464 (50.7) 0.019 308 (53.7) 0.002 464 (45.6) 0.63
T/T 72 (32.6) 108 (23.6) 59 (20.6) 108 (28.7)
T/C 104 (47.1) 236 (51.5) 148 (51.6) 236 (51.5)
C/C 45 (20.4) 114 (24.9) 0.04 80 (27.9) 0.0056 114 (19.9) 0.65
rs2687836 C 265 (60.0) 499 (54.5) 296 (51.6) 203 (59.4)
T 177 (40.0) 417 (45.5) 0.057 278 (48.4) 0.0077 139 (40.6) 0.87
C/C 81 (36.7) 131 (28.6) 73 (25.4) 58 (33.9)
C/T 103 (46.6) 237 (51.7) 150 (52.2) 87 (50.9)
T/T 37 (16.7) 90 (19.7) 0.1 64 (22.3) 0.019 26 (15.2) 0.7
Values given are the number of subjects, with the percentage in parentheses.
aP-value based on x
2 distribution.
doi:10.1371/journal.pone.0037501.t002
Table 3. Tg haplotype structure and frequencies
a.
SNP ID Haplotype comparison
b
Haplotype 18 20 AITD GD HT Controls AITD vs Controls
GD vs
Controls HT vs Controls
P-value P-value P-value
1 T C 0.49 0.46 0.54 0.55 0.025 0.001 0.73
2 C T 0.45 0.48 0.4 0.39 0.034 0.003 0.8
3 T T 0.055 0.056 0.053 0.046 0.47 0.45 0.69
aThe program, SNPAlyze ver. 7.0 Standard, was used to estimate common (frequencies .0.01) haplotypes for the two SNPs genotyped.
bEach haplotype was compared with the other haplotypes combined.
doi:10.1371/journal.pone.0037501.t003
Thyroglobulin Gene and AITD
PLoS ONE | www.plosone.org 4 May 2012 | Volume 7 | Issue 5 | e37501immune diseases. This mechanism has been shown to play a role
in the etiology of Type 1 (autoimmune) diabetes (T1D) [33].
Possible mechanism for the biological basis of these interactions is
that the susceptibility SNPs in Tg predispose to AITD by
influencing the formation of immunogenic peptides and their
presentation by HLA-DR3 to T-cells. However, further structural-
functional studies are required to substantiate this model [34].
The same 12 SNPs used in the present study were previously
studied in US Caucasian population, and exon 10–12 SNP cluster
and an exon 33 SNP were reported to be significantly associated
with both GD and HT, with a haplotype consisting of these two
SNP groups more strongly associated with and a gene-gene
interaction between HLA-DR3 and the exon 33 SNP suggested
[23]. However, these SNPs were not associated with the disease
and instead different SNPs in intron 41 were associated with GD,
but not HT, in the present study. Given the difference in HLA
between Japanese and Caucasian populations, different genetic
interaction between Tg peptides and HLA class II pockets may be
responsible for the differing Tg SNPs that are associated with
AITD in Japanese and Caucasian populations.
In conclusion, our results suggest that Tg is a susceptibility gene
for AITD and GD in the Japanese population. Therefore, it is
possible that that the Tg gene may predispose to AITD across
populations of different ethnic backgrounds. However, at this
stage, we cannot exclude that the 8q24 region harbors another
susceptibility locus (i.e. SAS-ZFAT) for AITD in linkage disequi-
librium with those SNPs of the Tg gene.
Supporting Information
Table S1 The pair-wise LD between 25 SNPs in the Tg gene
(PDF)
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